Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine?

7Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We recently conducted several studies regarding the presence of high-risk HPVs in human cervical, colorectal and breast cancers in the Syrian population. Herein, we report that high-risk HPVs type 16, 18, 33, 45, 51, 52 and 58 are frequently present in colorectal cancer in this population. Therefore and based on previous studies and present data, we conclude that the most frequent high-risk HPV types, in the Syrian population, are 16, 18, 33, 35, 45, 51, 52 and 58. Thus, our data suggest that it will be useful to use the new generation of HPV vaccine to protect the Syrian population from high-risk HPVs and their associated cancers. © 2012 Landes Bioscience.

Cite

CITATION STYLE

APA

Al Moustafa, A. E., Yasmeen, A., Ghabreau, L., & Akil, N. (2012). Does the Syrian population have to wait for the new generation of human papillomaviruses vaccine? Human Vaccines and Immunotherapeutics, 8(12), 1867–1868. https://doi.org/10.4161/hv.21973

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free